DrugsIn 2023, 2 novel pharmaceutical agents for small animals were released on the German market: the structural but non-functional analog of the inhibitory neurotransmitter gamma-aminobutyric acid pregabalin with an anxiolytic active component and the dopamine agonist ropinirole in form of eye drops ...
DrugsIn 2023, no new active pharmaceutical ingredients were released on the German market for horses and food-producing animals. Two established veterinary active pharmaceutical ingredients became available for additional species: The phosphorus compound butafosfan was also approved for horses, dogs, and...
Editorial: New drugs for treating COVID-19 cancer patientsdoi:10.3389/fendo.2023.1151942CANCER patientsCHINESE medicineKeng Po LaiRong LiKa WuWilliam Ka Fai TseFrontiers in Endocrinology
byDrugs.com Migraine Treatment The newest novel drug (approved March 9, 2023) for the treatment of migraine is Zavzpret (zavegepant) nasal spray. Migraine Prevention The newest drug (approved September 28, 2021) for the prevention of migraine (episodic migraine) is Qulipta (atogepant). ...
Alzheimer's disease (AD) is the leading cause of dementia, presenting a significant unmet medical need worldwide. The pathogenesis of AD involves various pathophysiological events, including the accumulation of amyloid and tau, neuro-inflammation, and ne
New drugs for type 2 diabetes mellitus: The challenge of the health care sustainability combined with a better patient care accessABSTRACTView further author informationhttps://orcid.org/0000-0003-2623-166XAntonio VitielloView further author information...
Some NMEs may eventually acquire at least one black box warning for serious adverse drug reactions or are withdrawn from the market for safety reasons not recognized at the time of approval. Therefore, while this review offers an introduction to some new drugs, it is essential that practitioners...
on July 6, 2023, for the treatment of AD [17]. The approval of this treatment not only affirms the pathophysiological significance of amyloid in AD but also marks a notable advance in clinical approaches to AD treatment, remedying the scarcity of new drugs in the market for nearly two dec...
作者: 2023年度美国🇺🇸FDA批准上市的新药,官网链接:网页链接。 new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2023 Chris De Savi另外制作了一个图。
Not all patients respond to, or are candidates for antisense oligonucleotides. They are not a cure for DMD, but may help improve muscle symptoms. Many of these drugs received accelerated approval by the FDA and still require clinical trials to confirm their clinical benefit in DMD. ...